Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

Journal of Antimicrobial Chemotherapy(2020)10.1093/jac/dkaa003Source: DataRank Database

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption is a research paper published in Journal of Antimicrobial Chemotherapy (2020). On theSindex it has a DataRank of 0.947. It has been cited 17 times, with 12 citing works in its 1-hop citation network.

N/A

0.947DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access17 citations · 12 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT02641756

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 1.88)OA: greenTopics (34)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 46%Citation Network 54%

Base Score Contribution

0.434

From this paper's citation signal

Citation Network Contribution

0.514

From 12 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 12 citers.

Neopterin Predicts Disease Severity in Hospitalized Patients With COVID-19
Open Forum Infectious Diseases202045 citations20 referencesContributes 0.191
Participant Perspectives and Experiences Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trials Group A5345 Biomarker Study
AIDS Research and Human Retroviruses202112 citations46 referencesContributes 0.056
Transient Viral Rebound in Children with Perinatally Acquired HIV-1 Induces a Unique Soluble Immunometabolic Signature Associated with Decreased CD4/CD8 Ratio
Journal of the Pediatric Infectious Diseases Society20234 citations32 referencesContributes 0.050
Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination
EBioMedicine20238 citations47 referencesContributes 0.047
Duration of antiretroviral therapy impacts the degree of residual SIV infection in the gut in long‐term non‐progressing Chinese rhesus macaques
Journal of Medical Virology20221 citations15 referencesContributes 0.046

Authors (16)

Clarissa Van Hecke ORCID,Henrik Zetterberg ORCID,Dietmar Fuchs ORCID,Nele De Langhe,Sofie Rutsaert ORCID

Live enrichment

PubMed:32053203 PMC:PMC7869780 OpenAlex:https://openalex.org/W3006512059

Merck Sharp & Dohme (MSD) investigator

Grant: ISS 52777

FWO

Grant: 1.8.020.09.N.00

Delaney AIDS Research Enterprise (DARE) to Find a Cure

Grant: 1U19AI096109

Delaney AIDS Research Enterprise (DARE) to Find a Cure

Grant: 1UM1AI126611-01

Delaney AIDS Research Enterprise to Cure HIV

Australian National Health and Medical Research Council

Grant: AAP1061681

European Research Council

Grant: 681712

Pathways to Alzheimer's disease

NIAID NIH HHS

Grant: U19 AI096109

Medical Research Council

Grant: UKDRI-1003

NIAID NIH HHS

Grant: UM1 AI126611

European Research Council

Grant: 720931

National Health and Medical Research Council (NHMRC)

Grant: 1061681

Characterising latent HIV reservoirs: examining the effects of treatment initiation, cellular type and patient genetics.

European Commission

Grant: 725422

The evolutionary dynamics of pathogen emergence and establishment: from Reservoir Detection to Outbreak Control

National Institutes of Health

Grant: 1U19AI096109-01

Administrative

NIH

Research Foundation Flanders

FWCI

1.88

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

greenLicense: OUP Standard Publication Reuse

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7869780

publisherhttp://academic.oup.com/jac/article-pdf/75/5/1311/36214013/dkaa003.pdf

journalhttps://doi.org/10.1093/jac/dkaa003

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32053203

Fields of Study

HIV Research and TreatmentHIV-related health complications and treatmentsHIV/AIDS Research and Interventions0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

APOBEC-3G DeaminaseHumansNuclear ProteinsRNA, ViralBiomarkersHIV-1HIV InfectionsViral Load

Keywords

Viral loadNeopterinBiomarkerImmune systemKynurenineMedicineImmunologyNeuroinflammationInflammationKynurenine pathwayBiologyVirologyVirusHIV-1HumansNuclear ProteinsRNA, ViralHIV InfectionsAPOBEC-3G DeaminaseBiomarkers

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being